Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agents

A. Romano, N. L. Parrinello, M. L. Consoli, L. Marchionni, S. Forte, C. Conticello, A. Pompa, A. Corso, G. Milone, F. Di Raimondo, I. Borrello

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agents'. Together they form a unique fingerprint.

Medicine & Life Sciences